Zetia Buyers Defend Class Cert. As 'Common Business Sense'
Direct buyers of cholesterol drug Zetia urged a Virginia federal court Tuesday to reject a recommendation against class certification in multidistrict litigation accusing Merck and Glenmark of scheming to delay generic...To view the full article, register now.
Already a subscriber? Click here to view full article